SHPA congratulates NSW Labor on winning Saturday’s 2023 State Election, at a pivotal time to build the specialised hospital pharmacy workforce in Australia’s most populous state.
Providing long-term certainty for Australia’s pharmacists and pharmacy technicians, SHPA has announced Medicines Management 2023 will be held in Cairns, 2-4 November 2023, and MM2024 will be held in Adelaide, 14-16 November 2024.
On Closing The Gap Day 2023, SHPA reiterates its call for action to reduce longstanding inequity in medicines access for Aboriginal and Torres Strait Islander patients receiving Pharmaceutical Benefits Scheme (PBS) medicines from hospitals, and formally declared its support for a First Nations Voice to Parliament.
Members of SHPA are a driving force behind many newly announced Medical Research Future Fund projects, following Federal Health Minister Mark Butler’s highly-anticipated $382 million announcement across nearly 200 projects, including ten funded under the 2022 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists grant opportunity.
SHPA has released its 2023 New South Wales State Election Priorities, calling on major parties, minor parties and independent candidates to end longstanding inequities to medicines access and access to hospital pharmacist workforce in New South Wales public hospitals.
SHPA is embracing equity on International Women's Day (IWD) 2023 and beyond, lifting up the experiences of members who continue to dominate leadership positions in the organisation and advocating for flexible, specialised pharmacy career pathways.
Australia’s newest conference for accredited, onsite aged care and GP pharmacists leading patient centred care is underway, and the SHPA Accredited Pharmacist Directory is now live, as delegates from across healthcare disciplines attending the opening of PharmCare 2023 in Hobart.
SHPA has supported the announcement by the Therapeutic Goods Administration (TGA) to recall pholcodine-containing medicines and remove them from the Australian Register of Therapeutic Goods (ARTG), as a regulatory decision that will improve patient safety and reduce medication-related harm.
Medication safety in pregnancy and breastfeeding, an international comparison on challenges and solutions in indigenous health care and access to a key anti-overdose intervention are among the many highlights in the third issue of the Australian Pharmacy Students’ Journal, the world’s first peer-reviewed pharmacy student journal.
A spotlight of diversity is shining on Sydney as World Pride 2023 invites the world to participate in a gathering and conversation, celebration and ceremony.
SHPA has entrenched its position as the leading voice on safe medicines management across all-important transitions of care, with senior members publishing expert opinion on barriers and enablers to implementation of hospital-initiated post-discharge medication reviews in Australia.
SHPA has welcomed the release of the Strengthening Medicare Taskforce Report, while reiterating that hospital-led expansion of pharmacists’ scope of practice is key to reforming and transforming Australia’s healthcare systems for greater sustainability and improved patient outcomes.
